[Federal Register Volume 67, Number 119 (Thursday, June 20, 2002)]
[Notices]
[Pages 42014-42018]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 02-15543]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention

[Program Announcement 02183]


Monitoring Prevalence of STDs and TB Infection in Persons 
Entering Corrections Facilities; Part A: Building Capacity for 
Monitoring STD and TB Prevalence; Part B: Enhanced Activities for 
Monitoring STD and TB Prevalence in Existing Sites; Notice of 
Availability of Funds

A. Purpose

    The Centers for Disease Control and Prevention (CDC) announces the 
availability of fiscal year (FY) 2002 funds for a cooperative agreement 
program for monitoring prevalence of sexually transmitted diseases 
(STDs) and tuberculosis (TB) infection in corrections facilities. This 
program addresses the ``Healthy People 2010'' focus area of Sexually 
Transmitted Diseases (STDs). Measurable outcomes of the program will be 
in alignment with one or more of the following performance goals for 
National Center for HIV, STD and TB Prevention:
    (1) Reduce the incidence of primary and secondary syphilis.
    (2) Reduce the incidence of congenital syphilis.
    (3) Eliminate tuberculosis in the United States.
    This program has two Parts. The purpose of Part A--Building 
Capacity for Monitoring STD and TB Prevalence is: (1) To develop 
systems for collecting and reporting STD and TB screening data in 
persons entering jails and juvenile detention facilities; and (2) to 
develop methods utilizing these data to help guide STD and TB 
prevention and intervention activities.
    The purpose of Part B--Enhanced Activities for Monitoring STD and 
TB Prevalence in Existing Sites is: (1) To enhance existing systems for 
collecting and reporting STD and TB screening data in persons entering 
jails and juvenile detention facilities; and (2) to develop, refine and 
identify the programmatic benefit of epidemiologic methods utilizing 
these data for prevention and intervention activity planning.

B. Authority and Catalog of Federal Domestic Assistance Number

    This program is authorized under sections 317E and 318 of the 
Public Health Service Act (42 U.S.C. sections 247b-6 and 247c). The 
Catalog of Federal Domestic Assistance number is 93.978.

C. Eligible Applicants

Part A

    Assistance will be provided only to the health departments of 
States or their bona fide agents, including the District of Columbia, 
the Commonwealth of Puerto Rico, the Virgin Islands, the Commonwealth 
of the Northern Mariana Islands, American Samoa, Guam, the Federated 
States of Micronesia, the Republic of the Marshall Islands, the 
Republic of Palau, and federally recognized Indian tribal governments. 
In consultation with States, assistance may be provided to political 
subdivisions of States. Project areas awarded funds in FY 1999, FY 
2000, or FY 2001 under Program Announcement 99000, ``Comprehensive STD 
Prevention System (CSPS), Monitoring Prevalence of STDs and TB 
Infection in Persons Entering Corrections Facilities' are not eligible 
for funding under Part A.

Part B

    Only project areas awarded funds in FY 1999, FY 2000, or FY 2001 
under Program Announcement 99000, ``Comprehensive STD Prevention System 
(CSPS), Monitoring Prevalence of STDs and TB Infection in Persons 
Entering Corrections Facilities,'' (i.e., Alabama, Arizona, Arkansas, 
Louisiana, Massachusetts, Missouri, North Carolina, Oregon, San 
Francisco, Rhode Island, Wisconsin) are eligible to apply for funds 
under Part B.

D. Availability of Funds

Part A

    Approximately $125,000 is available in FY 2002 to fund two to four 
awards.

[[Page 42015]]

It is expected that the average award will be $50,000, ranging from 
$30,000 to $70,000. It is expected that the awards will begin on or 
before September 30, 2002 and will be made for a 12-month budget period 
within a project period of up to two years. Funding estimates may 
change.

Part B

    Approximately $75,000 is available in FY 2002 to fund one to three 
awards. It is expected that the average award will be $30,000, ranging 
from $20,000 to $50,000. It is expected that the awards will begin on 
or before September 30, 2002 and will be made for a 12-month budget 
period within a project period of up to two years. Funding estimates 
may change.

Part A and B

    Continuation awards within an approved project period will be made 
on the basis of satisfactory progress as evidenced by required reports, 
data quality and timely submission, analyses performed and uses of data 
for providing epidemiologic guidance to STD and TB prevention and 
intervention activities, and the availability of funds.

Use of Funds

Part A
    Funds may be used to support personnel and to purchase equipment, 
supplies, and services directly related to project activities (i.e., 
improve the collection, management, and reporting of data). Funds may 
not be used to provide direct medical care.
Part B
    Funds may be used to support personnel and services that are 
related to project activities (i.e., enhance the collection, 
management, reporting, and analysis of data). Funds may not be used to 
provide direct medical care.
Recipient Financial Participation
    Grantees will be required to provide matching funds at a ratio of 
1:2 (i.e., $1 of new state or local, public or private resources for 
each $2 of federal resources awarded). New resources may include newly 
identified funds or newly identified in-kind resources.
Funding Preference
    Funding preference may be given to achieve geographical diversity.

E. Program Requirements (Part A and B)

    In conducting activities to achieve the purpose of this program, 
the recipient will be responsible for the activities under 1. Recipient 
Activities, and CDC will be responsible for the activities listed under 
2. CDC Activities.

Part A

1. Recipient Activities
    a. Design and implement a surveillance system that will address the 
study objectives in Section A by implementing a monitoring system for 
STDs and TB among persons entering corrections facilities.
    b. Collect data on at least 75 men per week and 25 women per week. 
If a single facility does not have this many entrants per week, 
multiple facilities may participate so as to provide the required 
sample size. Jail, juvenile, and prison facilities are eligible to 
participate. Both male and female inmates must be included in the 
project.
    c. Collect data that pertains to the first routine medical intake 
for men and women. Ideally, the intake should occur at the point of 
entry into the criminal justice system, but if not, it should occur 
before any medical care or treatment is provided. The intake should 
occur within 14 days of admission.
    d. Collect the following demographic and STD-related variables: 
Sex, age, race/ethnicity, zip code or census tract of residence, date 
of admission, symptoms (men only), and STD laboratory results. In 
addition, the following TB-related variables for each person tested 
must be collected: Country of birth, history of TB, prior Purified 
Protein Derivative (PPD) status, PPD result, and for those positive, 
chest x-ray findings and use of Isoniazid (INH) prophylaxis.
    e. Submit data in line-listed format quarterly to CDC.
    f. Analyze data in a manner that helps provide epidemiologic 
guidance to STD and TB prevention and intervention activities. Jail and 
juvenile chlamydia and/or gonorrhea screening data should be shared 
with the appropriate Regional Infertility Prevention Program Advisory 
Committee.
    g. Attendance for one to two project staff members at an annual 
principal investigator meeting is required.
    h. Participation in monthly conference calls is required.
2. CDC Activities
    a. Provide technical assistance in the design and conduct of the 
project.
    b. Conduct one site visit to each funded project for technical 
assistance.
    c. Assist in designing a data management system and designing data 
analyses to help guide STD and TB prevention and intervention 
activities.

Part B

1. Recipient Activities
    Applicants should have a proven history of having successfully 
implemented and sustained STD and TB prevalence data collection in a 
correctional facility as illustrated by addressing the following:
    a. Design and implement a surveillance system that will address the 
study objectives in section A by implementing a monitoring system for 
STDs and TB among persons entering corrections facilities.
    b. Collect data on at least 75 men per week and 25 women per week. 
If a single facility does not have this many entrants per week, 
multiple facilities may participate so as to provide the required 
sample size. Jail, juvenile, and prison facilities are eligible to 
participate. Both male and female inmates must be included in the 
project.
    c. Collect data that pertains to the first routine medical intake 
for men and women. Ideally, the intake should occur at the point of 
entry into the criminal justice system, but if not, it should occur 
before any medical care or treatment is provided. The intake should 
occur within 14 days of admission.
    d. Collect the following demographic and STD-related variables: 
Sex, age, race/ethnicity, zip code or census tract of residence, date 
of admission, symptoms (men only), and STD laboratory results. In 
addition, the following TB-related variables for each person tested are 
being collected: country of birth, history of TB, prior PPD status, PPD 
results, and for those positive, chest x-ray findings and use of INH 
prophylaxis. Additional variables collected for local use should be 
described.
    e. Submit data in line-listed format quarterly to CDC.
    f. Analyze data in a manner that helps provide epidemiologic 
guidance to STD and TB prevention and intervention activities. Jail and 
juvenile chlamydia and/or gonorrhea screening data should be shared 
with the appropriate Regional Infertility Prevention Program Advisory 
Committee.
    g. Attendance for one to two project staff members at an annual 
principal investigator meeting is required.
    h. Participation in monthly conference calls is required.

2. CDC Activities

    a. Provide technical assistance in the design and conduct of the 
project.
    b. Conduct one site visit to each funded project for technical 
assistance.

[[Page 42016]]

    c. Assist in designing a data management system and designing data 
analyses to help guide STD and TB prevention and intervention 
activities.

F. Application Content (Part A and B)

Letter of Intent (LOI)

    An LOI is required from potential applicants. The narrative should 
be no more than two double-spaced pages, printed on one side, with one-
inch margins, and unreduced font. The LOI should include the following: 
Program Announcement number 01283, name, address, and telephone number 
of a contact person and whether you intend to apply for Part A or Part 
B. The LOIs will be used to assist CDC in planning the application 
review process.

Applications

    The Program Announcement title and number must appear in the 
application. Use the information in the Program Requirements, Other 
Requirements, and Evaluation Criteria sections to develop the 
application content. Your application will be evaluated on the criteria 
listed, so it is important to follow them in laying out your proposal. 
The narrative should be no more than ten double-spaced pages, printed 
on one side, with one-inch margins, and unreduced font.
    The narrative should consist of, at minimum, a plan, objectives, 
methods, evaluation, and budget. Applicants may submit for more than 
one site for these activities, but the maximum amount of Federal funds 
awarded to each grantee will be limited to $70,000 (Part A) and $50,000 
(Part B).

Letter of Support

    Provide evidence of support from the corrections facility by 
attaching a letter in support of the proposal.

G. Submission and Deadline (Part A and B)

Letter of Intent (LOI)

    On or before July 12, 2002, submit the LOI to the Grants Management 
Specialist identified in the ``Where to Obtain Additional Information'' 
section of this announcement.

Application

    Submit the original and two copies of PHS 5161-1 (OMB Number 0920-
0428). Forms are available in the application kit and at the following 
Internet address: www.cdc.gov/od/pgo/forminfo.htm.
    Application packages must be submitted in the following order:

Cover letter
Table of Contents
Application
Budget Information Form
Budget Justification
Checklist
Assurances
Certification
Disclosure Form
HIV Assurance Form (if applicable)
Human Subjects Certification (if applicable)
Indirect Cost Rate Agreement (if applicable)
Narrative
    Applications must be submitted in hard copy form.

    The application must be received on or before July 31, 2002. Submit 
the application to: Technical Information Management--PA02183, 
Procurement and Grants Office, Centers for Disease Control and 
Infection, 2920 Brandywine Rd, Room 3000, Atlanta, GA 30341-4146.
    Deadline: Letters of intent and applications shall be considered as 
meeting the deadline if they are received before 5 P.M. Eastern Time on 
the deadline date. Applicants sending applications by the United States 
Postal Service or commercial delivery services must ensure that the 
carrier will be able to guarantee delivery of the application by the 
closing date and time. If an application is received after closing due 
to (1) carrier error, when the carrier accepted the package with a 
guarantee for delivery by the closing date and time, or (2) significant 
weather delays or natural disasters, CDC will upon receipt of proper 
documentation, consider the application as having been received by the 
deadline.
    Applications which do not meet the above criteria will not be 
eligible for competition and will be discarded. Applicants will be 
notified of their failure to meet the submission requirements.

G. Evaluation Criteria

Application

    Applicants are required to provide measures of effectiveness that 
will demonstrate the accomplishment of the various identified 
objectives of the cooperative agreement. Measures of effectiveness must 
relate to the performance goals stated in section ``A. Purpose'' of 
this announcement. Measures must be objective and quantitative and must 
measure the intended outcome. These measures of effectiveness shall be 
submitted with the application and shall be an element of evaluation.
    Each application will be evaluated individually against the 
following criteria by an independent review group appointed by CDC:
Part A
    1. Plan: The degree to which the applicant describes the project 
plan and indicates a time frame for project activities. The extent to 
which the plan addresses each of the program requirements listed below. 
(20 points)
    The application should include:
    a. A description of the extent of collaboration between the health 
department and corrections facility for the purpose of implementing 
routine STD and TB screening and data collection as evidenced by a 
letter of support from the corrections facility.
    b. A description of who would be offered STD and TB services and 
which services would be offered.
    c. A description of changes, if any, that would be made to the 
current system, with respect to medical services provided, data 
collected, data management.
    d. A description of the proposed data analyses and the extent to 
which these analyses will help provide epidemiologic guidance to STD 
and TB prevention and intervention activities.
    e. The degree to which the applicant adequately addresses the CDC 
Policy requirements regarding the inclusion of women, ethnic, and 
racial groups in the proposed activities. (5 points) This includes:
    1. The proposed plan for the inclusion of both sexes and racial and 
ethnic minority populations for appropriate representation.
    2. The proposed justification when representation is limited or 
absent.
    3. A statement as to whether the design of the project is adequate 
to measure differences when warranted.
    4. A statement as to whether the plans include the process of 
establishing partnerships with communities and recognition of mutual 
benefits.
    2. Objectives: The degree to which the applicant describes how the 
project proposes to develop systems for collecting and reporting STD 
and TB screening data in persons entering jails and juvenile detention 
facilities and to develop methods utilizing these data to help guide 
STD and TB prevention and intervention activities. (20 points)
    The application should include:
    a. A description that addresses the method by which and the extent 
to which STD/TB prevalence data or other data collected in conjunction 
with STD/TB data will be used to help provide epidemiologic guidance 
and otherwise inform STD and TB programmatic prevention and 
intervention activities.
    b. Expertise of project staff to analyze data and to develop future 
analytic plans. Also include a plan for

[[Page 42017]]

dissemination of findings to local public health agencies, corrections 
officials, and Regional Infertility Prevention Program Advisory 
Committees for use in providing guidance to STD and TB control 
prevention and intervention activities.
    c. The extent to which the number of men and women per week for 
whom data will be submitted exceeds the required 75 men and 25 women 
per week at the participating jails.
    3. Methods: The degree to which the methods described for 
implementing and evaluating data collection and analyses are 
appropriate. (20 points)
    The application should include:
    a. A description of participating corrections facilities: Include 
daily census, intakes per week for men and women (include breakdown by 
age group and race/ethnicity, if available), average length of stay, 
and where inmates come from (area of draw, referral patterns).
    b. A description that includes the extent to which all core STD 
data elements (presence of genital ulcer, urethral discharge in men 
only, syphilis test results, stage of syphilis, gonorrhea results, 
chlamydia results, HIV results, pregnancy test results) and TB data 
elements (country of birth, history of TB, prior PPD status, PPD 
results, and for those positive, chest x-ray findings and use of INH 
prophylaxis) will be collected.
    c. A description of the extent of medical services at intake: 
Describe medical services provided at intake, including how many days 
after admission services are provided, and whether medical history, 
physical exam, and lab testing are completed. State whether inmates are 
asked about STD or TB symptoms routinely, if all receive STD tests (and 
which STD tests are routinely conducted) and tuberculin skin tests 
(TST), and what follow-up care is provided for STD and TST positive 
persons on site.
    d. A description of data management: Describe the management of STD 
and TB data routinely collected at intake. Describe what data are 
recorded and where. Explain what computerized data systems, if any, are 
in place and describe what computerized system will be used for this 
project.
    e. A description and explanation of the methods that will be used 
to determine the percentage of eligible detainees that are tested.
    4. Evaluation Plan: The degree to which the applicant provides a 
plan for evaluating the accuracy and completeness of the data provided 
by the corrections facility that is appropriate and comprehensive. The 
application should include a description and extent to which a plan for 
evaluating how these data will be used to help provide epidemiologic 
guidance to STD and TB prevention and intervention activities. (20 
points)
    5. Sustainability of the project: The degree to which project 
activities will be integrated with existing STD and TB surveillance 
activities and will be continued without this source of funding. Please 
explain why successful activities developed by this proposal can be 
sustained past the duration of the project period and what will ensure 
that this happens. (15 points)
    6. Budget: The degree to which the budget is reasonable, clearly 
justified and consistent with the intent of the announcement. The 
matching funds requirement is not scored, however it is reflected in 
the evaluation criteria (criteria number 5) related to the 
sustainability of the program. (not scored)
    7. Human Subjects: The extent to which the application adequately 
addresses the requirements of Title 45 CFR Part 46 for the protection 
of human subjects. (not scored)
Part B
    1. Objectives: The degree to which the applicant describes how the 
project proposes to enhance existing systems for collecting and 
reporting STD and TB screening data in persons entering jails and 
juvenile detention facilities and to develop and refine epidemiologic 
methods utilizing these data for prevention and intervention activity 
planning. (30 points)
    The application should include:
    a. A description that includes a plan for using the STD/TB 
prevalence data or other data collected as part of this project to help 
provide epidemiologic guidance and otherwise inform STD and TB 
programmatic prevention and intervention activities and for 
demonstrating the programmatic benefit of having such data available.
    b. A description of the current ability of staff to analyze data 
and of future analytic plans. Also a plan for dissemination of findings 
to local public health agencies, corrections officials, and Regional 
Infertility Prevention Program Advisory Committees for use in providing 
guidance to STD and TB control prevention and intervention activities.
    c. The extent to which the number of men and women per week for 
whom data are submitted exceeds the required 75 men and 25 women per 
week at the participating jails.
    2. Methods: The degree to which the applicant describes methods for 
implementing and evaluating the data collection and analyses that are 
appropriate. (20 points)
    The application should include:
    a. A description of current and new (if applicable) participating 
corrections facilities: Include daily census, intakes per week for men 
and women (include breakdown by age group and race/ethnicity, if 
available), average length of stay, and where inmates come from (area 
of draw, referral patterns).
    b. The extent to which medical services are provided at intake: 
Describe medical services provided at intake, including how many days 
after admission services are provided, and whether medical history, 
physical exam, and lab testing are completed. State whether inmates are 
asked about STD or TB symptoms routinely, if all receive STD tests (and 
which STD tests are routinely conducted) and TST, and what follow up 
care is provided for STD and TST positive persons on site.
    c. A description of the data management plan: Describe the 
management of STD and TB data routinely collected at intake. Describe 
what data are recorded and where.
    d. The extent to which STD/TB prevalence data or other data 
collected in conjunction with these data are being, or will be, used to 
help provide epidemiologic guidance to STD and TB prevention and 
intervention activities.
    e. A description of what new data and/or methods will be used in 
future activities should also be included.
    f. A description and explanation of the methods that are used to 
determine the percentage of eligible detainees that are tested.
    3. Plan: The degree to which the applicant describes the current 
and future project plans and indicates a time frame for new project 
activities. The plan should address each of the program requirements 
listed below. (15 points)
    The application should include:
    a. The extent of collaboration between the health department and 
corrections facility for the purpose of conducting routine STD and TB 
screening and data collection as evidenced by a letter of support from 
the corrections facility or facilities.
    b. A description of currently offered STD and TB services and what 
new services would be offered.
    c. A description that includes the extent to which all core STD 
data elements (presence of genital ulcer, urethral discharge men only, 
syphilis test results, stage of syphilis, gonorrhea results, chlamydia 
results, HIV results, pregnancy test results) and TB data elements 
(country of birth, history of TB, prior PPD status, PPD results, and

[[Page 42018]]

for those positive, chest x-ray findings and use of INH prophylaxis) 
are currently collected and plans for future collection of these data 
elements or plans for collecting other variables to be used in local 
analyses.
    d. The degree to which the applicant adequately addresses the CDC 
Policy requirements regarding the inclusion of women, ethnic, and 
racial groups in the proposed activities. (5 points) This includes:
    1. The proposed plan for the inclusion of both sexes and racial and 
ethnic minority populations for appropriate representation.
    2. The proposed justification when representation is limited or 
absent.
    3. A statement as to whether the design of the project is adequate 
to measure differences when warranted.
    4. A statement as to whether the plans include the process of 
establishing partnerships with communities and recognition of mutual 
benefits.
    4. Sustainability of the project: The degree to which project 
activities have been integrated with existing STD and TB surveillance 
activities and will be continued without this source of funding. The 
degree to which the applicant explains why successful activities 
developed by this proposal can be sustained past the duration of the 
project period and what will ensure that this happens. (15 points)
    5. Evaluation Plan: The degree to which the applicant's plan for 
evaluating the accuracy and completeness of the data provided by the 
corrections facility is appropriate and comprehensive. The application 
should include a description of the extent of current and future 
evaluations with regard to how the data is used currently and how the 
data will be used to help provide epidemiologic guidance to STD and TB 
prevention and intervention activities. (15 points)
    6. Budget: The degree to which the budget is reasonable, clearly 
justified and consistent with the intent of the announcement. The 
matching funds requirement is not scored, however it is reflected in 
the evaluation criteria (criteria number 4) related to the 
sustainability of the program. (not scored)
    7. Human Subjects: The extent to which the application adequately 
addresses the requirements of Title 45 CFR Part 46 for the protection 
of human subjects. (not scored)

I. Other Requirements (Part A and B)

Technical Reporting Requirements

    Provide CDC with original plus two copies of
    1. Annual progress reports. The progress report will include a data 
requirement that demonstrates measures of effectiveness.
    2. Financial status report, no or than 90 days after the end of the 
budget period.
    3. Final financial and performance reports, no more than 90 days 
after the end of the project period.

Send all reports to the Grants Management Specialist identified in the 
``Where to Obtain Additional Information'' section of this 
announcement.
    The following additional requirements are applicable to this 
program:

AR-1  Human Subjects Requirements
AR-2  Requirements for Inclusion of Women and Racial and Ethnic 
Minorities in Research
AR-4  HIV/AIDS Confidentiality Provisions
AR-5  HIV Program Review Panel Requirements
AR-7  Executive Order 12372
AR-9  Paperwork Reduction Act Requirements
AR-10  Smoke-Free Workplace Requirements
AR-11  Healthy People 2010
AR-14  Accounting System Requirements
AR-22  Research Integrity

J. Where To Obtain Additional Information

    This and other CDC announcements can be found on the CDC Home Page 
Internet address http://www.cdc.gov Click on ``Funding'' then ``Grants 
and Cooperative Agreements.''
    To obtain business management technical assistance, contact: Jesse 
L. Robertson, Grants Management Specialist, Grants Management Branch, 
Procurement and Grants Office, Centers for Disease Control 
and Prevention (CDC), 2920 Brandywine Road, Room 3000 Mailstop E-15, 
Atlanta, Georgia 30341-4146, Telephone: (770) 488-2747, E-mail Address: 
[email protected].
    For program technical assistance, contact:

Richard Kahn, MS, Epidemiology and Surveillance Branch, Division of STD 
Prevention, National Center for HIV, STD and TB Prevention, Centers for 
Disease Control and Prevention (CDC), 1600 Clifton Road, N.E., Mailstop 
E-02, Atlanta, GA 30333, Telephone Number: (404) 639-8956, E-mail 
Address: [email protected],

or

Joe Posid, MPH, Division of TB Elimination, National Center for HIV, 
STD, TB Prevention, Centers for Disease Control and Prevention (CDC), 
1600 Clifton Road, N.E., Mailstop E-27, Atlanta, GA, 30333, Telephone 
Number: (404) 639-1855, E-mail Address: [email protected].

    Dated: June 14, 2002.
Sandra R. Manning, CGFM,
Director, Procurement and Grants Office, Centers for Disease Control 
and Prevention.
[FR Doc. 02-15543 Filed 6-19-02; 8:45 am]
BILLING CODE 4163-18-P